Click here to get full coverage on TRI-611, a selective, brain-penetrant molecular glue degrader of ALK - Nature

TRI-611, a selective, brain-penetrant molecular glue degrader of ALK  Nature

TRI-611, a selective, brain-penetrant molecular glue degrader of ALK - Nature

Click here to get full coverage on Ensartinib Treatment for Rare Nonclassical ALK Fusion Lung Adenocarcinoma With Brain Metastasis - cancernetwork.com

Ensartinib Treatment for Rare Nonclassical ALK Fusion Lung Adenocarcinoma With Brain Metastasis  cancernetwork.com

Ensartinib Treatment for Rare Nonclassical ALK Fusion Lung Adenocarcinoma With Brain Metastasis - cancernetwork.com

Click here to get full coverage on ALK to present at the Morgan Stanley Global Healthcare Conference in New York - Yahoo Finance

ALK to present at the Morgan Stanley Global Healthcare Conference in New York  Yahoo Finance

ALK to present at the Morgan Stanley Global Healthcare Conference in New York - Yahoo Finance

Click here to get full coverage on Alaska Air Group (ALK) Faces Earnings Pressure, Is The Stock Fully Priced? - simplywall.st

Alaska Air Group (ALK) Faces Earnings Pressure, Is The Stock Fully Priced?  simplywall.st

Alaska Air Group (ALK) Faces Earnings Pressure, Is The Stock Fully Priced? - simplywall.st

Click here to get full coverage on Alkemy Capital Investments PLC Share Price - ALK, RNS News, Articles, Quotes, & Charts (LON:ALK) - Proactive financial news

Alkemy Capital Investments PLC Share Price - ALK, RNS News, Articles, Quotes, & Charts (LON:ALK)  Proactive financial news

Alkemy Capital Investments PLC Share Price - ALK, RNS News, Articles, Quotes, & Charts (LON:ALK) - Proactive financial news

Click here to get full coverage on ALK Maintained by Barclays -- Price Target Lowered to $52.00 - GuruFocus

ALK Maintained by Barclays -- Price Target Lowered to $52.00  GuruFocus

ALK Maintained by Barclays -- Price Target Lowered to $52.00 - GuruFocus

Click here to get full coverage on Ensartinib in Resected ALK -Positive Non–Small-Cell Lung Cancer - NEJM

Ensartinib in Resected ALK -Positive Non–Small-Cell Lung Cancer  NEJM

Ensartinib in Resected ALK -Positive Non–Small-Cell Lung Cancer - NEJM

Click here to get full coverage on Here's Why Alaska Air Group (ALK) Fell More Than Broader Market - Yahoo Finance

Here's Why Alaska Air Group (ALK) Fell More Than Broader Market  Yahoo Finance

Here's Why Alaska Air Group (ALK) Fell More Than Broader Market - Yahoo Finance

Click here to get full coverage on ALK-Vac Anti-Tumor Resistance Vaccine Shows Promise in ALK+ NSCLC - cancertherapyadvisor.com

ALK-Vac Anti-Tumor Resistance Vaccine Shows Promise in ALK+ NSCLC  cancertherapyadvisor.com

ALK-Vac Anti-Tumor Resistance Vaccine Shows Promise in ALK+ NSCLC - cancertherapyadvisor.com

Click here to get full coverage on ALK-negative anaplastic large cell lymphoma in pediatric and adolescent patients: a mini-review - Frontiers

ALK-negative anaplastic large cell lymphoma in pediatric and adolescent patients: a mini-review  Frontiers

ALK-negative anaplastic large cell lymphoma in pediatric and adolescent patients: a mini-review - Frontiers

Click here to get full coverage on ALK Maintained by UBS -- Price Target Lowered to $52.00 - GuruFocus

ALK Maintained by UBS -- Price Target Lowered to $52.00  GuruFocus

ALK Maintained by UBS -- Price Target Lowered to $52.00 - GuruFocus

Click here to get full coverage on Alaska Air Group (ALK) Stock Looks Undervalued Despite a 31% One Year Fall - simplywall.st

Alaska Air Group (ALK) Stock Looks Undervalued Despite a 31% One Year Fall  simplywall.st

Alaska Air Group (ALK) Stock Looks Undervalued Despite a 31% One Year Fall - simplywall.st

Click here to get full coverage on Alaska Air (ALK) Down 7.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Alaska Air (ALK) Down 7.1% Since Last Earnings Report: Can It Rebound?  Yahoo Finance

Alaska Air (ALK) Down 7.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Click here to get full coverage on Alaska Air Group (ALK) Stock May Be Below Fair Value As New Europe Flights Loom - Yahoo Finance

Alaska Air Group (ALK) Stock May Be Below Fair Value As New Europe Flights Loom  Yahoo Finance

Alaska Air Group (ALK) Stock May Be Below Fair Value As New Europe Flights Loom - Yahoo Finance

Click here to get full coverage on Alaska Air Group (ALK) Following CEO Buying And New Routes Has Value Back In Focus - Yahoo Finance

Alaska Air Group (ALK) Following CEO Buying And New Routes Has Value Back In Focus  Yahoo Finance

Alaska Air Group (ALK) Following CEO Buying And New Routes Has Value Back In Focus - Yahoo Finance

Click here to get full coverage on ALK appoints Jacob Glenting as head of Global R&D - Yahoo Finance

ALK appoints Jacob Glenting as head of Global R&D  Yahoo Finance

ALK appoints Jacob Glenting as head of Global R&D - Yahoo Finance

Click here to get full coverage on Will Alaska Air (ALK)ʼs New Seattle–Europe Routes Redefine Its International Growth Narrative? - Yahoo Finance

Will Alaska Air (ALK)ʼs New Seattle–Europe Routes Redefine Its International Growth Narrative?  Yahoo Finance

Will Alaska Air (ALK)ʼs New Seattle–Europe Routes Redefine Its International Growth Narrative? - Yahoo Finance

Click here to get full coverage on Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff - Yahoo Finance

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff  Yahoo Finance

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff - Yahoo Finance

Click here to get full coverage on ALK- and ROS1-Positive NSCLC: Emerging Treatment Options - Oncology News Central

ALK- and ROS1-Positive NSCLC: Emerging Treatment Options  Oncology News Central

ALK- and ROS1-Positive NSCLC: Emerging Treatment Options - Oncology News Central

Click here to get full coverage on Adjuvant Ensartinib Improves DFS in Resected ALK-Positive NSCLC - cancernetwork.com

Adjuvant Ensartinib Improves DFS in Resected ALK-Positive NSCLC  cancernetwork.com

Adjuvant Ensartinib Improves DFS in Resected ALK-Positive NSCLC - cancernetwork.com

Click here to get full coverage on Insights Into ALK-Rearranged NSCLC Management From ASCO 2026 - Medscape Reference: Drugs, Diseases & Medical Procedures

Insights Into ALK-Rearranged NSCLC Management From ASCO 2026  Medscape Reference: Drugs, Diseases & Medical Procedures

Insights Into ALK-Rearranged NSCLC Management From ASCO 2026 - Medscape Reference: Drugs, Diseases & Medical Procedures

Click here to get full coverage on ALK to Report Q2 Earnings: What's in the Offing for the Stock? - Yahoo Finance

ALK to Report Q2 Earnings: What's in the Offing for the Stock?  Yahoo Finance

ALK to Report Q2 Earnings: What's in the Offing for the Stock? - Yahoo Finance

Click here to get full coverage on Is Most-Watched Stock Alaska Air Group, Inc. (ALK) Worth Betting on Now? - Yahoo Finance

Is Most-Watched Stock Alaska Air Group, Inc. (ALK) Worth Betting on Now?  Yahoo Finance

Is Most-Watched Stock Alaska Air Group, Inc. (ALK) Worth Betting on Now? - Yahoo Finance

Click here to get full coverage on Alaska Air Group (ALK) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Alaska Air Group (ALK) Reports Q2 Loss, Lags Revenue Estimates  Yahoo Finance

Alaska Air Group (ALK) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Living Well and Community Building Among Patients with ALK-Positive NSCLC - curetoday.com

Living Well and Community Building Among Patients with ALK-Positive NSCLC  curetoday.com

Living Well and Community Building Among Patients with ALK-Positive NSCLC - curetoday.com

Click here to get full coverage on CircRNAs derived from the tyrosine phosphatase PTPN22 impact chemosensitivity in ALK-positive T-cell lymphomas - Nature

CircRNAs derived from the tyrosine phosphatase PTPN22 impact chemosensitivity in ALK-positive T-cell lymphomas  Nature

CircRNAs derived from the tyrosine phosphatase PTPN22 impact chemosensitivity in ALK-positive T-cell lymphomas - Nature

Click here to get full coverage on ELEVATE Trial Shows Disease-Free Survival Benefit With Adjuvant Ensartinib in ALK-Positive NSCLC - The ASCO Post

ELEVATE Trial Shows Disease-Free Survival Benefit With Adjuvant Ensartinib in ALK-Positive NSCLC  The ASCO Post

ELEVATE Trial Shows Disease-Free Survival Benefit With Adjuvant Ensartinib in ALK-Positive NSCLC - The ASCO Post

Click here to get full coverage on Jessica J. Lin, MD, on Neladalkib in Advanced ALK-Positive NSCLC - The ASCO Post

Jessica J. Lin, MD, on Neladalkib in Advanced ALK-Positive NSCLC  The ASCO Post

Jessica J. Lin, MD, on Neladalkib in Advanced ALK-Positive NSCLC - The ASCO Post

Click here to get full coverage on Earnings Preview: Alaska Air Group (ALK) Q2 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Alaska Air Group (ALK) Q2 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Alaska Air Group (ALK) Q2 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff - Yahoo Finance UK

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff  Yahoo Finance UK

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff - Yahoo Finance UK

Click here to get full coverage on Alaska Air (ALK) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Alaska Air (ALK) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates  Yahoo Finance

Alaska Air (ALK) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Click here to get full coverage on ROS1 vs ALK Positive NSCLC: Treatment Differences & Strategies - Oncology News Central

ROS1 vs ALK Positive NSCLC: Treatment Differences & Strategies  Oncology News Central

ROS1 vs ALK Positive NSCLC: Treatment Differences & Strategies - Oncology News Central

Click here to get full coverage on Alaska Air Group (ALK) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Alaska Air Group (ALK) Stock Sinks As Market Gains: What You Should Know  Yahoo Finance

Alaska Air Group (ALK) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Click here to get full coverage on The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinib - Nature

The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinib  Nature

The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinib - Nature

Click here to get full coverage on Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC - OncLive

Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC  OncLive

Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC - OncLive

Click here to get full coverage on San Diego is getting its only nonstop flight to Loreto. Alaska starts Dec. 19. - Stock Titan

San Diego is getting its only nonstop flight to Loreto. Alaska starts Dec. 19.  Stock Titan

San Diego is getting its only nonstop flight to Loreto. Alaska starts Dec. 19. - Stock Titan

Click here to get full coverage on ALK - Alaska Air Group Inc Stock Price and Quote - Finviz

ALK - Alaska Air Group Inc Stock Price and Quote  Finviz

ALK - Alaska Air Group Inc Stock Price and Quote - Finviz

Click here to get full coverage on Alaska Air Group (ALK) Stock Could Be 19.8% Overvalued After Oil Relief And SAF Progress - Yahoo Finance

Alaska Air Group (ALK) Stock Could Be 19.8% Overvalued After Oil Relief And SAF Progress  Yahoo Finance

Alaska Air Group (ALK) Stock Could Be 19.8% Overvalued After Oil Relief And SAF Progress - Yahoo Finance

Click here to get full coverage on Is Alkane Resources (ASX:ALK) Cheap Following Storheden Drilling Results? - Yahoo Finance

Is Alkane Resources (ASX:ALK) Cheap Following Storheden Drilling Results?  Yahoo Finance

Is Alkane Resources (ASX:ALK) Cheap Following Storheden Drilling Results? - Yahoo Finance

Click here to get full coverage on ALK-positive Spitz nevus of the nasal dorsum in a child: a case report and literature review - Frontiers

ALK-positive Spitz nevus of the nasal dorsum in a child: a case report and literature review  Frontiers

ALK-positive Spitz nevus of the nasal dorsum in a child: a case report and literature review - Frontiers

Click here to get full coverage on Neladalkib Earns FDA Priority Review in ALK-Positive NSCLC - cancernetwork.com

Neladalkib Earns FDA Priority Review in ALK-Positive NSCLC  cancernetwork.com

Neladalkib Earns FDA Priority Review in ALK-Positive NSCLC - cancernetwork.com

Click here to get full coverage on ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight - PR Newswire

ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight  PR Newswire

ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight - PR Newswire

Click here to get full coverage on Alaska Air Group (ALK) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance

Alaska Air Group (ALK) Suffers a Larger Drop Than the General Market: Key Insights  Yahoo Finance

Alaska Air Group (ALK) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance

Click here to get full coverage on FDA Grants Priority Review to Neladalkib NDA for ALK-Positive NSCLC - targetedonc.com

FDA Grants Priority Review to Neladalkib NDA for ALK-Positive NSCLC  targetedonc.com

FDA Grants Priority Review to Neladalkib NDA for ALK-Positive NSCLC - targetedonc.com

Click here to get full coverage on Alaska Air Group (ALK) Valuation Check As Shares Rebound Over The Past Week - Yahoo Finance

Alaska Air Group (ALK) Valuation Check As Shares Rebound Over The Past Week  Yahoo Finance

Alaska Air Group (ALK) Valuation Check As Shares Rebound Over The Past Week - Yahoo Finance

Click here to get full coverage on Newer Agents Hope to Raise the Bar in ALK- and RET-Positive NSCLC - OncLive

Newer Agents Hope to Raise the Bar in ALK- and RET-Positive NSCLC  OncLive

Newer Agents Hope to Raise the Bar in ALK- and RET-Positive NSCLC - OncLive

Click here to get full coverage on ARCHER Trial: Prophylactic ALK Resistance Vaccine in Advanced ALK-Positive NSCLC - Oncodaily

ARCHER Trial: Prophylactic ALK Resistance Vaccine in Advanced ALK-Positive NSCLC  Oncodaily

ARCHER Trial: Prophylactic ALK Resistance Vaccine in Advanced ALK-Positive NSCLC - Oncodaily

Click here to get full coverage on Wall Street Thinks Alaska Air (ALK) Could Outperform Over The Next Year - Yahoo Finance

Wall Street Thinks Alaska Air (ALK) Could Outperform Over The Next Year  Yahoo Finance

Wall Street Thinks Alaska Air (ALK) Could Outperform Over The Next Year - Yahoo Finance

Click here to get full coverage on Finding Purpose After a Stage 4 ALK-Positive Lung Cancer Diagnosis - curetoday.com

Finding Purpose After a Stage 4 ALK-Positive Lung Cancer Diagnosis  curetoday.com

Finding Purpose After a Stage 4 ALK-Positive Lung Cancer Diagnosis - curetoday.com

Click here to get full coverage on Dr Gerber on the Neurocognitive Tradeoffs of Later-Generation ALK TKIs in NSCLC - OncLive

Dr Gerber on the Neurocognitive Tradeoffs of Later-Generation ALK TKIs in NSCLC  OncLive

Dr Gerber on the Neurocognitive Tradeoffs of Later-Generation ALK TKIs in NSCLC - OncLive

Click here to get full coverage on Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement - Frontiers

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement  Frontiers

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement - Frontiers

Click here to get full coverage on Alaska Air Group (ALK) Stock May Trade At A Discount Even As Earnings Look Rich - Yahoo Finance

Alaska Air Group (ALK) Stock May Trade At A Discount Even As Earnings Look Rich  Yahoo Finance

Alaska Air Group (ALK) Stock May Trade At A Discount Even As Earnings Look Rich - Yahoo Finance

Click here to get full coverage on Why Alaska Air Group (ALK) Stock Is Down Today - Quiver Quantitative

Why Alaska Air Group (ALK) Stock Is Down Today  Quiver Quantitative

Why Alaska Air Group (ALK) Stock Is Down Today - Quiver Quantitative

Click here to get full coverage on Brokers Suggest Investing in Alaska Air (ALK): Read This Before Placing a Bet - Yahoo Finance

Brokers Suggest Investing in Alaska Air (ALK): Read This Before Placing a Bet  Yahoo Finance

Brokers Suggest Investing in Alaska Air (ALK): Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on Insights Into Alaska Air (ALK) Q2: Wall Street Projections for Key Metrics - Yahoo Finance

Insights Into Alaska Air (ALK) Q2: Wall Street Projections for Key Metrics  Yahoo Finance

Insights Into Alaska Air (ALK) Q2: Wall Street Projections for Key Metrics - Yahoo Finance

Click here to get full coverage on Biomarker Testing and Treatment Selection in ALK-Positive NSCLC - curetoday.com

Biomarker Testing and Treatment Selection in ALK-Positive NSCLC  curetoday.com

Biomarker Testing and Treatment Selection in ALK-Positive NSCLC - curetoday.com

Click here to get full coverage on Alaska Air Group (ALK) Nears Earnings As Hawaiian Integration Narrative Points To Undervalued Shares - Yahoo Finance

Alaska Air Group (ALK) Nears Earnings As Hawaiian Integration Narrative Points To Undervalued Shares  Yahoo Finance

Alaska Air Group (ALK) Nears Earnings As Hawaiian Integration Narrative Points To Undervalued Shares - Yahoo Finance

Click here to get full coverage on Tony S.K. Mok, MD, FRCPC, FASCO, on Advanced ALK-Positive NSCLC: 7-Year Update From the CROWN Trial - The ASCO Post

Tony S.K. Mok, MD, FRCPC, FASCO, on Advanced ALK-Positive NSCLC: 7-Year Update From the CROWN Trial  The ASCO Post

Tony S.K. Mok, MD, FRCPC, FASCO, on Advanced ALK-Positive NSCLC: 7-Year Update From the CROWN Trial - The ASCO Post

Click here to get full coverage on Alaska Air Group (ALK) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Alaska Air Group (ALK) Stock Sinks As Market Gains: Here's Why  Yahoo Finance

Alaska Air Group (ALK) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Click here to get full coverage on ALK-positive large B-cell lymphoma presenting in the nasal cavity with CLTC::ALK fusion: a case report of alectinib-integrated therapy followed by autologous hematopoietic stem cell transplantation - Frontiers

ALK-positive large B-cell lymphoma presenting in the nasal cavity with CLTC::ALK fusion: a case report of alectinib-integrated therapy followed by autologous hematopoietic stem cell transplantation  Frontiers

ALK-positive large B-cell lymphoma presenting in the nasal cavity with CLTC::ALK fusion: a case report of alectinib-integrated therapy followed by autologous hematopoietic stem cell transplantation - Frontiers

Click here to get full coverage on Alkane Resources (ASX:ALK) Is Up 15.4% After Expanding High-Grade Swedish Gold Resources - What's Changed - Yahoo Finance

Alkane Resources (ASX:ALK) Is Up 15.4% After Expanding High-Grade Swedish Gold Resources - What's Changed  Yahoo Finance

Alkane Resources (ASX:ALK) Is Up 15.4% After Expanding High-Grade Swedish Gold Resources - What's Changed - Yahoo Finance

Click here to get full coverage on Assessing Alaska Air Group (ALK) Valuation After A Year Of Share Price Weakness - Yahoo Finance

Assessing Alaska Air Group (ALK) Valuation After A Year Of Share Price Weakness  Yahoo Finance

Assessing Alaska Air Group (ALK) Valuation After A Year Of Share Price Weakness - Yahoo Finance

Click here to get full coverage on AAL, UAL, ALK, JBLU And Other Airline Stocks Are Flying Higher Today — Crude Prices Fall To Multi-Week Lows - Yahoo Finance

AAL, UAL, ALK, JBLU And Other Airline Stocks Are Flying Higher Today — Crude Prices Fall To Multi-Week Lows  Yahoo Finance

AAL, UAL, ALK, JBLU And Other Airline Stocks Are Flying Higher Today — Crude Prices Fall To Multi-Week Lows - Yahoo Finance

Click here to get full coverage on Research Updates and Future Perspectives in ALK-Positive NSCLC - curetoday.com

Research Updates and Future Perspectives in ALK-Positive NSCLC  curetoday.com

Research Updates and Future Perspectives in ALK-Positive NSCLC - curetoday.com

Click here to get full coverage on Is Alaska Air Group’s (ALK) Starlink Wi‑Fi Rollout a Signal on Its Competitive Strategy? - Yahoo Finance

Is Alaska Air Group’s (ALK) Starlink Wi‑Fi Rollout a Signal on Its Competitive Strategy?  Yahoo Finance

Is Alaska Air Group’s (ALK) Starlink Wi‑Fi Rollout a Signal on Its Competitive Strategy? - Yahoo Finance

Click here to get full coverage on Alaska Air Group (ALK) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance

Alaska Air Group (ALK) Registers a Bigger Fall Than the Market: Important Facts to Note  Yahoo Finance

Alaska Air Group (ALK) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance

Click here to get full coverage on Minimal residual disease guides postoperative therapy in a patient with ALK-rearranged adenocarcinoma: a case report - Frontiers

Minimal residual disease guides postoperative therapy in a patient with ALK-rearranged adenocarcinoma: a case report  Frontiers

ALK

Price Chart

Key Statistics

Technicals

About ALK

Latest News

TRI-611, a selective, brain-penetrant molecular glue degrader of ALK - Nature

Ensartinib Treatment for Rare Nonclassical ALK Fusion Lung Adenocarcinoma With Brain Metastasis - cancernetwork.com

ALK to present at the Morgan Stanley Global Healthcare Conference in New York - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers